###begin article-title 0
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Tat Stimulates Transcription Complex Assembly through Recruitment of TBP in the Absence of TAFs
###end article-title 0
###begin article-title 1
###xml 38 41 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A New Paradigm in Eukaryotic Biology: HIV Tat and the Control of Transcriptional Elongation
###end article-title 1
###begin article-title 2
###xml 3 6 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
An HIV Protein Plays a Surprising Role in Gene Activation
###end article-title 2
###begin p 3
###xml 4 32 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 470 475 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 756 761 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The human immunodeficiency virus type I (HIV-1) transactivator protein Tat is an unusual transcriptional activator that is thought to act solely by promoting RNA polymerase II processivity. Here we study the mechanism of Tat action by analyzing transcription complex (TC) assembly in vivo using chromatin immunoprecipitation assays. We find, unexpectedly, that like typical activators Tat dramatically stimulates TC assembly. Surprisingly, however, the TC formed on the HIV-1 long terminal repeat is atypical and contains TATA-box-binding protein (TBP) but not TBP-associated factors (TAFs). Tat function involves direct interaction with the cellular cofactor positive transcription elongation factor b (P-TEFb). Artificial tethering of P-TEFb subunits to HIV-1 promoter DNA or nascent RNA indicates that P-TEFb is responsible for directing assembly of a TC containing TBP but not TAFs. On the basis of this finding, we identify P-TEFb-dependent cellular promoters that also recruit TBP in the absence of TAFs. Thus, in mammalian cells transcription of protein-coding genes involves alternative TCs that differ by the presence or absence of TAFs.
###end p 3
###begin p 4
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The transcriptional activator, HIV-1 Tat, not only acts by promoting RNA polymerase processivity, but it is able to promote transcription complex assembly in the absence of TATA- box-binding protein-associated factors
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b01">1</xref>
###xml 841 842 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b02">2</xref>
###xml 843 844 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b03">3</xref>
###xml 845 846 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b04">4</xref>
In eukaryotes, gene regulation is largely controlled at the transcriptional level. Factors involved in the accurate transcription of eukaryotic structural genes by RNA polymerase II (class II genes) can be classified into two groups. First, general (or basic) transcription factors (GTFs) are necessary and can be sufficient for accurate transcription initiation in vitro (for review, see [1]). Such factors include RNA polymerase II itself and at least six GTFs: TFIID, TFIIA, TFIIB, TFIIE, TFIIF, and TFIIH. The GTFs assemble on the core promoter in an ordered fashion to form a transcription pre-initiation complex (PIC). The first step in PIC assembly is binding of the GTF TFIID to the TATA box. TFIID is a multi-subunit complex consisting of the TATA-box-binding protein (TBP) and a set of tightly bound TBP-associated factors (TAFs) [2,3,4].
###end p 6
###begin p 7
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b05">5</xref>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b06">6</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b01">1</xref>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b07">7</xref>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b08">8</xref>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b09">9</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b10">10</xref>
Transcriptional activity is greatly stimulated by the second class of factors, promoter-specific activator proteins (activators). In general, cellular activators are sequence-specific DNA-binding proteins whose recognition sites are usually present in sequences upstream of the core promoter (reviewed in [5,6]). In addition to a sequence-specific DNA-binding domain, a typical activator also contains a separable activation domain. A variety of studies indicate that activators work, at least in part, by increasing PIC formation through a mechanism thought to involve direct interactions with one or more components of the transcription machinery [1,7,8,9]. Activators can also act through other mechanisms, such as increasing the rate of transcriptional elongation, promoting multiple rounds of transcription, and directing chromatin modifications (reviewed in [10]).
###end p 7
###begin p 8
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b11">11</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b12">12</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b13">13</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b14">14</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b15">15</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b11">11</xref>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b12">12</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b13">13</xref>
###xml 19 47 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 796 801 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Tat protein of human immunodeficiency virus type I (HIV-1) is a potent activator of the viral long terminal repeat (LTR) and is required for viral replication (reviewed in [11,12,13]). Unlike typical activators, which bind to promoter DNA, Tat binds to nascent viral RNA through an RNA-binding site termed the TAR element. Tat function involves direct interaction with the cellular cofactor called positive transcription elongation factor b (P-TEFb), which is composed of two subunits, cyclin T1 (CycT1) and CDK9 (reviewed in [14,15]). Several lines of evidence have suggested that unlike typical activators, Tat stimulates transcriptional elongation rather than initiation. According to the current model (reviewed in [11,12,13]), in the absence of Tat, RNA polymerase II initiates from the HIV-1 LTR in a form unable to elongate efficiently and thus stalls (or pauses) near the transcription start site. When present, Tat binds to TAR and recruits P-TEFb, allowing CDK9 to phosphorylate the C-terminal domain of the RNA polymerase II large subunit, thereby increasing transcriptional processivity.
###end p 8
###begin p 9
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b16">16</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b17">17</xref>
###xml 225 230 <span type="species:ncbi:4932">yeast</span>
###xml 477 482 <span type="species:ncbi:4932">yeast</span>
The chromatin immunoprecipitation (ChIP) assay has provided a powerful approach to study in vivo the mechanism by which activators stimulate transcription and to delineate the composition of transcription complexes (TCs). In yeast, ChIP analysis has been used to show that activators function, at least in part, by stimulating TC assembly. These studies have also revealed that at certain promoters TBP is recruited in the absence of TAFs [16,17], indicating that, at least in yeast, some TCs contain TBP but not TFIID. Here we perform ChIP experiments to study the mechanism of transcription activation by Tat in vivo.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Experimental Design
###end title 11
###begin p 12
To analyze transcription stimulation by Tat and other activators we performed ChIP experiments in transiently transfected mammalian tissue culture cells. Plasmids expressing a reporter construct, containing a core promoter and various combinations of activator-binding sites, were transiently transfected into HeLa or 293T cells. In some experiments, a second plasmid expressing an activator was co-transfected. Reporter activity or primer extension was used to quantitate transcription levels. TC assembly was analyzed by a ChIP assay using antibodies directed against components of four representative GTFs involved in distinct stages of TC assembly: TFIID (TBP and typically TAF1 and TAF5), TFIIB, mediator (CDK8 and hMed6), and RNA polymerase II (RBP1). In most experiments the analysis was performed using two sets of primers: one set encompassed the core promoter, transcription start site, and immediate downstream region, and a second set was located far downstream of the transcription start site, within the open reading frame (ORF).
###end p 12
###begin title 13
Diverse Activators Function by Increasing TC Assembly
###end title 13
###begin p 14
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b18">18</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b19">19</xref>
###xml 3 8 <span type="species:ncbi:4932">yeast</span>
###xml 381 385 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
In yeast, it has been shown that activators stimulate TC assembly, which is evident at the earliest step of this process, interaction of TBP with the TATA box [18,19]. To confirm that this was also the case in mammalian cells, we used a ChIP assay to analyze TC assembly in three well-characterized model systems: transcription directed by Gal4-VP16, transcription directed by the SV40 enhancer, and transcription directed by the adenovirus (Ad) E1a protein.
###end p 14
###begin p 15
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b05">5</xref>
###xml 198 206 198 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g001">Figure 1</xref>
The artificial activator Gal4-VP16 contains an unusually potent acidic activation domain and can stimulate transcription in many species and cell types including mammalian tissue culture cells [5]. Figure 1A shows, consistent with previous studies, that on a synthetic promoter containing four Gal4-binding sites upstream of the TATA box, transcription was not detectable in the absence of Gal4-VP16, whereas addition of Gal4-VP16 led to a large transcriptional increase. The accompanying ChIP assay shows that in the absence of Gal4-VP16 there was no detectable association of GTFs with the promoter. However, addition of Gal4-VP16 led to a large increase in recruitment of all GTFs analyzed, explaining the transcriptional stimulation. Consistent with the transcription results, RNA polymerase II was associated with the ORF in the presence but not absence of Gal4-VP16. Also, as expected, the GTFs were associated with the core promoter and not the ORF.
###end p 15
###begin p 16
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b20">20</xref>
###xml 258 269 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 393 395 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b21">21</xref>
###xml 398 406 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g001">Figure 1</xref>
###xml 450 461 447 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 702 713 696 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 443 449 <span type="species:ncbi:9986">rabbit</span>
###xml 569 573 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 635 639 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 745 749 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Transcription of certain genes requires a cis-acting enhancer element that is often located at a distance from the transcription start site (reviewed in [20]). The enhancer functions by providing binding sites for cellular activators. For example, a minimal beta-globin promoter is inefficiently expressed, but addition of an appropriate enhancer element dramatically increases transcription [21]. Figure 1B shows, as expected, that a minimal rabbit beta-globin promoter was virtually inactive, whereas transcriptional activity was greatly increased by addition of the SV40 enhancer. The ChIP analysis shows that in the absence of the SV40 enhancer there was no detectable association of GTFs with the beta-globin promoter. Upon addition of the SV40 enhancer, there was a large increase in GTF recruitment that correlated with the increased transcriptional activity.
###end p 16
###begin p 17
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b22">22</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b23">23</xref>
###xml 422 430 422 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g001">Figure 1</xref>
Finally, we analyzed transcription directed by the Ad E1a protein. Efficient transcription from Ad early promoters requires the viral E1a protein as well as the participation of cellular transcription factors that also bind to the promoter (reviewed in [22]). For example, the Ad E4 promoter contains multiple binding sites for cellular ATF proteins, which are required for efficient transcription activation by E1a [23]. Figure 1C shows, as expected, that in the absence of E1a there was only a background level of Ad E4 transcription, and that E1a increased transcription dramatically. The accompanying ChIP assay shows that in the absence of E1a there was no significant association of GTFs with the promoter, whereas transfection of E1a resulted in recruitment of all GTFs analyzed in a manner that paralleled the increased transcriptional activity.
###end p 17
###begin p 18
###xml 27 35 27 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g001">Figure 1</xref>
###xml 52 57 <span type="species:ncbi:4932">yeast</span>
###xml 190 195 <span type="species:ncbi:4932">yeast</span>
In summary, the results of Figure 1 indicate, as in yeast, that in three well-studied higher eukaryotic examples, transcription activation involves promotion of TC assembly. Moreover, as in yeast, the stimulatory effect is evident at the earliest step of TC assembly, the TBP- TATA box interaction.
###end p 18
###begin title 19
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 Tat Protein Stimulates TC Assembly through Recruitment of TBP in the Absence of TAFs
###end title 19
###begin p 20
###xml 102 110 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g002">Figure 2</xref>
###xml 314 322 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g002">Figure 2</xref>
###xml 623 631 623 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g002">Figure 2</xref>
###xml 789 797 789 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g002">Figure 2</xref>
###xml 1212 1214 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b12">12</xref>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b24">24</xref>
###xml 1249 1257 1249 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g002">Figure 2</xref>
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 206 211 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 502 507 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1133 1138 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We next investigated Tat-mediated transcription activation and TC assembly on the HIV-1 LTR promoter. Figure 2A shows, as expected, that in the absence of Tat there was no detectable transcription from the HIV-1 LTR, and that addition of Tat increased transcription dramatically. The accompanying ChIP experiment (Figure 2A, left) shows that in the absence of Tat, association of GTFs with the core promoter was virtually undetectable. Sp1, a constitutive cellular activator that binds upstream of the HIV-1 core promoter was, as expected, associated with the promoter in the absence of Tat and unaffected by Tat addition (Figure 2A, right). Significantly, in the absence of Tat there was no detectable association of RNA polymerase II near the transcription start site or within the ORF (Figure 2A, left). However, following addition of Tat, there was a large increase in association of TBP, TFIIB, mediator, and RNA polymerase II with the promoter, which paralleled the transcriptional increase. Also, as expected, there was a large increase in association of RNA polymerase II with the ORF. Following recruitment of P-TEFb to the HIV-1 LTR by Tat, P-TEFb associates with and phosphorylates RNA polymerase II [12,24]. Accordingly, the ChIP assay (Figure 2A, right) shows that in the presence of Tat the two P-TEFb subunits, CycT1 and CDK9, were present at both the promoter and the ORF. Unexpectedly, although TBP and the other GTFs were efficiently recruited to the promoter in the presence of Tat, there was no significant recruitment of the two TAFs analyzed, TAF1 or TAF5 (left panel).
###end p 20
###begin p 21
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b25">25</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b11">11</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b12">12</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b13">13</xref>
We note that recruitment of Tat was not observed in the ChIP assay, which detects proteins bound either directly or indirectly to DNA (reviewed in [25]). Unlike all the other transcription factors, which associate with the TC through DNA-protein or protein-protein interactions, Tat is bound to nascent RNA [11,12,13].
###end p 21
###begin p 22
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b26">26</xref>
###xml 241 249 241 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g002">Figure 2</xref>
###xml 128 133 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To determine whether the lack of TAF recruitment was a general feature of Tat-directed transcription, we analyzed a chronically HIV-1-infected cell line, 8E5/LAV, which harbors an integrated provirus that is constitutively transcribed [26]. Figure 2B shows that TBP, TFIIB, mediator, Sp1, P-TEFb, and RNA polymerase II, but not TAF1 or TAF5, were associated with the integrated proviral promoter, consistent with the results of the transient transfection assay.
###end p 22
###begin p 23
###xml 488 490 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b27">27</xref>
###xml 491 493 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b28">28</xref>
###xml 641 649 637 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g002">Figure 2</xref>
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 384 389 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 584 589 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 690 695 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We also analyzed a second chronically HIV-1-infected cell line, U1, which has been used as a model to study viral latency. U1 cells harbor an integrated viral genome, but, unlike 8E5/LAV cells, the constitutive level of viral expression is extremely low. Viral expression can be induced by phorbol esters, which stimulate transcription through upstream NF-kappaB-binding sites in the HIV-1 LTR, leading to Tat synthesis and a subsequent substantial Tat-mediated transcriptional increase [27,28]. Thus, U1 cells provide an experimental system to analyze TC assembly from an integrated HIV-1 LTR in the inactive (-PMA) or active (+PMA) state. Figure 2C shows that following activation of the HIV-1 LTR by PMA addition, there was a large increase in recruitment of TBP and RNA polymerase II, whereas TAF1 and TAF5 were once again not detected.
###end p 23
###begin p 24
###xml 369 377 366 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g003">Figure 3</xref>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 618 623 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 728 733 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 919 924 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To investigate further the composition of the TC formed on the HIV-1 LTR, we obtained a panel of antibodies directed against nine additional human TAFs (TAF2, TAF4, TAF6, TAF7, TAF8, TAF9, TAF11, TAF12, and TAF13), as well as antibodies against four subunits of the S TAGA complex (PAF65beta, hSpt3, hGCN5, and TRRAP) and the TBP-interacting protein Mot1. The results (Figure 3A) show that when transcription was directed by Gal4-VP16, all 11 TAFs analyzed were bound to the promoter, as expected for recruitment of TFIID. By contrast, when transcription was directed by Tat, none of the 11 TAFs were recruited to the HIV-1 LTR. Gal4-VP16 also recruited all four S TAGA subunits analyzed, none of which were associated with the HIV-1 LTR in the presence of Tat. Finally, Mot1 was not recruited when transcription was directed by either Gal4-VP16 or Tat. On the basis of these data we conclude that the TC formed on the HIV-1 LTR lacks at least 11, and probably all, of the 14 TFIID TAFs. In the experiments presented below, TAF1 and TAF5 were analyzed as representative TAFs.
###end p 24
###begin title 25
TAFs Are Not Required for Tat-Mediated Transcription Activation
###end title 25
###begin p 26
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b29">29</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b30">30</xref>
###xml 371 379 371 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g003">Figure 3</xref>
###xml 776 784 776 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g003">Figure 3</xref>
###xml 978 986 978 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g003">Figure 3</xref>
###xml 1143 1151 1143 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g003">Figure 3</xref>
###xml 1235 1240 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The results of the ChIP experiments strongly suggested that transcription activation by Tat did not require TAFs. To confirm this supposition, we examined the ability of Tat to stimulate transcription following TAF inactivation. First, we examined the ability of Tat to activate transcription in ts13 cells, which harbor a temperature-sensitive mutation in TAF1 [29,30]. Figure 3B shows, as expected, that inactivation of TAF1 significantly diminished transcription activation by VP16 and E1a, whereas Tat-mediated transcription activation was unaffected. In a second approach, we used short hairpin RNAs (shRNAs) to knockdown expression of TAF5 or TAF12 in 293A cells. Immunoblot analysis confirmed that shRNA-mediated knockdown of TAF expression was efficient and specific (Figure 3C, left). Transcriptional analysis revealed that knockdown of TAF5 or TAF12 substantially decreased transcription directed by VP16, whereas Tat-mediated transcription activation was unaffected (Figure 3C, right). (Because 293A cells are transformed by and express E1a, activation by E1a could not be analyzed in this experiment.) Collectively, the results of Figure 3 demonstrate that TAFs are not involved in transcription activation directed by the HIV-1 Tat protein.
###end p 26
###begin title 27
Tat and P-TEFb Direct Recruitment of TBP in the Absence of TAFs
###end title 27
###begin p 28
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 296 301 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The results described above indicate that on the HIV-1 LTR transcription activation involves assembly of an atypical TC that contains TBP but not TAFs. However, these experiments do not distinguish whether the critical determinant for recruitment of TBP and not TFIID is Tat or the promoter, the HIV-1 LTR. To address this issue we performed a series of artificial tethering experiments.
###end p 28
###begin p 29
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b31">31</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b32">32</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b33">33</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b32">32</xref>
###xml 429 437 429 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g004">Figure 4</xref>
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 182 187 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 523 528 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 893 898 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Previous studies have shown that Tat can activate transcription when directed to the HIV-1 LTR through a heterologous DNA-binding domain [31,32,33]. We analyzed TC assembly using an HIV-1 LTR derivative that lacked the TAR element and contained upstream Gal4-binding sites. We first examined the TCs formed on this promoter by three Gal4 fusion proteins: Gal4-VP16, Gal4-E1a, and Gal4-Tat. Consistent with previous studies [32], Figure 4 shows that all three Gal4 fusion proteins activated transcription from this modified HIV-1 LTR derivative. The accompanying ChIP experiments show that Gal4-VP16 and Gal4-E1a supported assembly of a TC that contained all of the GTFs, including TAF1 and TAF5. By contrast, Gal4-Tat directed assembly of a TC in which the TAFs were present at a level significantly below that of TBP and other GTFs. These results indicate that the activator Tat, and not the HIV-1 LTR promoter, directs the selective recruitment of TBP in the absence of TAFs.
###end p 29
###begin p 30
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b34">34</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b35">35</xref>
As discussed above, Tat interacts directly with CycT1, a subunit of the transcription elongation factor P-TEFb. Thus, Tat is an adaptor whose function is to recruit P-TEFb. We therefore considered that P-TEFb was ultimately responsible for the selective recruitment of TBP in the absence of TAFs. To address this possibility, we analyzed transcription activation by the two P-TEFb subunits, CycT1 and CDK9. Consistent with previous results [34,35], both Gal4-CycT1 and Gal4-CDK9 activated transcription. The ChIP analysis indicates that both Gal4-CycT1 and Gal4-CDK9 stimulated assembly of a TC that contained all of the GTFs but lacked TAF1 and TAF5. These results confirm that P-TEFb is responsible for directing selective recruitment of TBP in the absence of TAFs.
###end p 30
###begin p 31
###xml 28 36 28 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g004">Figure 4</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b36">36</xref>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b36">36</xref>
###xml 81 86 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 342 347 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 629 634 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 727 732 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In the experiments shown in Figure 4, P-TEFb was tethered to DNA, whereas on the HIV-1 LTR, P-TEFb is normally bound through Tat to nascent RNA. We therefore sought to verify that P-TEFb, when bound to nascent RNA, would also selectively recruit TBP in the absence of TAFs. Previous studies have shown that recruitment of CycT1/P-TEFb to the HIV-1 LTR through a heterologous RNA-binding domain can activate transcription in the absence of Tat [36]. We therefore asked whether such an artificially recruited CycT1/P-TEFb protein would stimulate assembly of a TC that contained TBP but not TAFs. We used a previously characterized HIV-1 LTR derivative [36] in which the TAR element was replaced by a minimal binding site for the HIV-1 Rev protein, and examined the ability of a Rev-Tat or Rev-CycT1 fusion protein to stimulate TC assembly.
###end p 31
###begin p 32
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g005">Figure 5</xref>
Figure 5 shows that in the absence of a Rev fusion protein, both transcription and GTF recruitment were virtually undetectable. Addition of Rev-Tat or Rev-CycT1 resulted in a large transcriptional increase, as expected from previous studies. Significantly, addition of Rev-Tat or Rev-CycT1 also led to a large increase in recruitment of TBP, TFIIB, mediator, and RNA polymerase II, but not TAF1 or TAF5. Thus, in the absence of Tat, Rev-CycT1 stimulated assembly of a TC that contained TBP but not TAFs.
###end p 32
###begin title 33
Identification of Cellular Promoters That Recruit TBP in the Absence of TAFs
###end title 33
###begin p 34
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b37">37</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b38">38</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b39">39</xref>
P-TEFb is also a cofactor for several cellular activators, the best studied of which is CIITA, a transcription factor involved in the expression of major histocompatibility complex (MHC) class II genes (reviewed in [37]). In fact, overexpression of Tat can inhibit transcription of MHC class II genes by competing with CIITA for P-TEFb binding [38,39].
###end p 34
###begin p 35
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DM</italic>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR,</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 286 292 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DM</italic>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR</italic>
###xml 383 391 383 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g006">Figure 6</xref>
###xml 427 433 427 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DM</italic>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR</italic>
###xml 549 554 549 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
We therefore tested whether the promoters of MHC class II genes also recruited an atypical TC that contained TBP but not TAFs. We analyzed two MHC class II genes known to use CIITA, HLA-DM and HLA-DR, and, as a negative control, GAPDH. RT-PCR analysis confirmed, as expected, that both HLA-DM and HLA-DR were expressed in 293T cells (data not shown). The associated ChIP experiment (Figure 6) shows that the TCs formed on both HLA-DM and HLA-DR contained all of the GTFs but lacked significant levels of TAF1 and TAF5. By contrast, the TC formed on GAPDH contained all of the GTFs, including TAF1 and TAF5. These results indicate that TBP, and not TFIID, is also selectively recruited to specific cellular promoters and strongly support the conclusion that P-TEFb directs this recruitment.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b11">11</xref>
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b12">12</xref>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b13">13</xref>
###xml 326 331 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 366 371 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 536 540 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
A variety of studies have proposed that Tat promotes transcriptional elongation [11,12,13]. However, the effect of Tat on TC assembly in vivo has not been previously analyzed. In this report, we studied the mechanism of Tat action using ChIP assays and found, unexpectedly, that Tat dramatically stimulates TC assembly on the HIV-1 LTR. Perhaps most surprising, the HIV-1 LTR contains an atypical TC that lacks TFIID and that has not been previously described in mammalian cells. By contrast, transcription activation by Gal4-VP16, the SV40 enhancer, or the Ad E1a protein involves assembly of a TC that contains TFIID. Thus, our results reveal mechanistic similarities between apparently diverse classes of activators and unanticipated differences in the composition of mammalian TCs.
###end p 37
###begin p 38
###xml 200 202 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b12">12</xref>
###xml 552 554 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b40">40</xref>
###xml 6 11 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 189 194 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 701 706 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In an HIV-1-infected cell, a low level of Tat-independent transcription can be elicited by cellular activators, such as Sp1, NF-kappaB, and NFAT, which are bound to upstream regions of the HIV-1 LTR [12]. Tat is recruited to the vicinity of the promoter by binding to this low level of nascent TAR RNA, where it facilitates subsequent rounds of TC assembly and transcription initiation. Thus, once a threshold level of transcription is achieved, Tat stimulates additional transcription, thereby increasing the number of Tat-binding sites (reviewed in [40]). This positive feedback mechanism would ensure that viral transcription rapidly increases or decreases, which may be relevant to the ability of HIV-1 to enter latency and, conversely, to be activated from the latent state.
###end p 38
###begin title 39
Tat Stimulates TC Assembly
###end title 39
###begin p 40
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b41">41</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b42">42</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b43">43</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b44">44</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b41">41</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b45">45</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b46">46</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b47">47</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b42">42</xref>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b43">43</xref>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b48">48</xref>
###xml 1520 1522 1520 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b49">49</xref>
###xml 1697 1699 1697 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b50">50</xref>
###xml 460 465 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1351 1356 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1400 1405 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Previous studies have provided two principal lines of evidence that Tat functions by stimulating transcription elongation. First, Tat has been found to stimulate elongation in an in vivo nuclear run-off assay [41,42,43,44], and in the absence of Tat, apparent prematurely terminated transcripts have been detected [41,45]. However, these in vivo results are complicated by the presence of a second promoter, the initiator of short transcripts, adjacent to the HIV-1 LTR [46,47]. In our experiments RNA polymerase II was not detected either near or far downstream of the transcription start site in the absence of Tat and thus provided no evidence for a paused (or stalled) RNA polymerase II. Consistent with our ChIP data, nuclear run-off experiments have shown that Tat increases the density of RNA polymerase II 9- to 15-fold within the first 25 nucleotides downstream of the transcription start site [42,43], indicating that Tat also stimulates initiation. A second line of evidence has been derived from in vitro experiments in which Tat was found to enhance elongation but not initiation (see, for example, [48]). However, in vitro transcription experiments may fail to faithfully recapitulate in vivo regulation: for example, under in vitro conditions using naked DNA templates, PIC assembly and initiation may no longer be rate-limiting on the HIV-1 LTR. Consistent with this possibility, the HIV-1 LTR is a relatively strong promoter when analyzed as naked DNA in vitro in the absence of Tat (see, for example, [49]). Moreover, initiation effects would not be observed if the cell-free system did not support multiple rounds of transcription from a single DNA template (see, for example, [50]).
###end p 40
###begin p 41
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b11">11</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b12">12</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b13">13</xref>
It is important to emphasize that our ChIP assay only analyzed TC assembly. Thus, our results do not rule out the possibility that in addition to stimulating TC assembly, Tat also promotes transcription elongation. Based upon the results presented here and previous studies (reviewed in [11,12,13]), we believe that Tat stimulates TC assembly, thereby promoting initiation and elongation. This dual mechanism of action may explain why Tat is such a potent activator of transcription.
###end p 41
###begin title 42
Tat and P-TEFb Direct Recruitment of TBP in the Absence of TAFs
###end title 42
###begin p 43
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b02">2</xref>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b03">3</xref>
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b04">4</xref>
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 327 332 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We have shown that transcription from the HIV-1 LTR involves TBP but not TFIID. This result was particularly unexpected because in mammalian cells TBP is bound to TAFs extremely tightly and numerous biochemical studies have failed to find free TBP [2,3,4]. None of the 11 TAFs, four S TAGA subunits, or Mot1 was present on the HIV-1 LTR, strongly suggesting that free TBP is recruited. However, we cannot exclude the possibility that TBP may be associated with unknown proteins that remain to be identified.
###end p 43
###begin p 44
###xml 555 566 555 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 606 611 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 847 853 836 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DM</italic>
###xml 859 865 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR</italic>
###xml 1049 1057 1038 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0030044-g004">Figure 4</xref>
###xml 582 585 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 772 775 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 795 800 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 806 809 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 827 830 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Several considerations rule out the possibility that TFIID is actually present in the TC directed by Tat/P-TEFb but that the TAFs are not detected in the ChIP assay. First, numerous studies have shown ChIP to be a remarkably general and robust assay that has successfully detected a wide variety of activators, general initiation and elongation components, chromatin remodeling factors, and histone variants. Second, in experiments not involving Tat or P-TEFb, TAFs were detected at levels comparable to that of TBP on five different promoters (G4E1bCAT, beta-globin, E4CAT, G6(-83)HIV LTRDeltaTARCAT, and GAPDH). Third, when TC assembly was directed by Tat or P-TEFb the ChIP assay detected all GTFs analyzed, including TBP, but not TAFs on six different promoters ([-83]HIV LTRCAT, integrated HIV-1/LAV, HIV SLIIBCAT, G6[-83]HIV LTRDeltaTARCAT, HLA-DM, and HLA-DR]. Finally, and perhaps most persuasively, on the same promoter the presence or absence of TAFs as monitored by ChIP was dictated solely by the upstream bound Gal4 fusion protein (see Figure 4).
###end p 44
###begin p 45
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b14">14</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b15">15</xref>
Artificial tethering experiments clearly demonstrate that P-TEFb directs recruitment of TBP in the absence of TAFs. Strongly supporting this conclusion is our identification of cellular promoters for which P-TEFb is a cofactor and whose TC contains TBP but not TAFs. How P-TEFb selectively recruits TBP and not TFIID remains to be determined. It has been previously thought that P-TEFb is purely an elongation factor [14,15]. However, we have shown that when tethered to DNA or nascent RNA, P-TEFb can also stimulate TC assembly and dictate the composition of the TC.
###end p 45
###begin p 46
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b16">16</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b17">17</xref>
###xml 3 8 <span type="species:ncbi:4932">yeast</span>
###xml 390 395 <span type="species:ncbi:4932">yeast</span>
###xml 513 518 <span type="species:ncbi:4932">yeast</span>
In yeast, promoters have been grouped into two extreme classes based on their requirement for TAFs [16,17]. TAF-dependent promoters require TAFs for transcription, and on these promoters TBP and TAFs are present at comparable levels. TAF-independent promoters do not require TAFs for activity, and on these promoters TAFs are either absent or present at levels far below that of TBP. These yeast results are strikingly similar to the findings reported here, and taken together these results indicate that in both yeast and mammalian cells, transcription of protein-coding genes involves alternative TCs that differ by the presence or absence of TAFs.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48

###end title 48
###begin title 49
Plasmids
###end title 49
###begin p 50
###xml 197 208 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 406 408 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b51">51</xref>
###xml 429 440 426 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 502 504 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b52">52</xref>
###xml 753 755 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b53">53</xref>
###xml 847 849 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b54">54</xref>
###xml 896 898 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b36">36</xref>
###xml 259 263 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 330 334 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 698 701 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 767 770 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 789 792 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 856 859 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To generate the G4E1bCAT construct, pDSG39, four Gal4-binding sites were inserted upstream of the E1b TATA box and the CAT ORF in the vector pSP72 (Promega, Madison, Wisconsin, United States). The beta-globin constructs containing (pBS) or lacking (pB/E) the SV40 enhancer were provided by Walter Schaffner; pBS contains a 196-bp SV40 enhancer-containing fragment inserted into a plasmid derived from pB6 [51], which harbors the beta-globin gene. The E4CAT construct, pE4CAT, was previously described [52]. The pFR-Luc plasmid, containing five Gal4-binding sites upstream of the E1b TATA box and the luciferase reporter gene, was obtained from Stratagene (La Jolla, California, United States). The HIV LTR-luciferase construct was previously described [53]. The (-83)HIV LTRCAT and G6(-83)HIV LTRDeltaTARCAT constructs, were previously described [54]. The HIV SLIIBCAT construct, pHIV/SLIIB/CAT [36], was provided by Bryan Cullen.
###end p 50
###begin p 51
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b55">55</xref>
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b52">52</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b56">56</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b52">52</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b36">36</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b55">55</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b36">36</xref>
###xml 95 98 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Plasmids expressing the Gal4-VP16 fusion protein (pGal4-VP16; [55]), E1a (pSV-E1a; [52]), Tat (CMV-Tat; [56]), and the Gal4-E1a fusion protein (pGal4-E1a; [52]) were previously described. To generate pGal4-Tat, pGal4-CycT1, and pGal4-CDK9, the full-length Tat protein, the hCycT1-containing EcoR1 fragment from phCycT1-Rev [36], or the CDK9-containing EcoR1 fragment from pSG5-CDK9 (a gift from Claude Gazin), respectively, were individually cloned into plasmid pSG424 [55] as an in-frame fusion with the Gal4 DNA-binding domain. Rev fusion-protein plasmids pTAT-Rev and phCycT1-Rev [36] were obtained from Bryan Cullen.
###end p 51
###begin title 52
Antibodies
###end title 52
###begin p 53
###xml 810 812 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b57">57</xref>
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 53 57 <span type="species:ncbi:9925">goat</span>
###xml 91 95 <span type="species:ncbi:9925">goat</span>
###xml 130 134 <span type="species:ncbi:9925">goat</span>
###xml 168 172 <span type="species:ncbi:9925">goat</span>
###xml 206 210 <span type="species:ncbi:9925">goat</span>
###xml 245 251 <span type="species:ncbi:9986">rabbit</span>
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
###xml 324 329 <span type="species:ncbi:10090">mouse</span>
###xml 361 367 <span type="species:ncbi:9986">rabbit</span>
###xml 413 418 <span type="species:ncbi:10090">mouse</span>
###xml 564 569 <span type="species:ncbi:10090">mouse</span>
###xml 675 681 <span type="species:ncbi:9986">rabbit</span>
###xml 830 835 <span type="species:ncbi:10090">mouse</span>
###xml 1034 1040 <span type="species:ncbi:9986">rabbit</span>
###xml 1110 1116 <span type="species:ncbi:9986">rabbit</span>
###xml 1192 1198 <span type="species:ncbi:9986">rabbit</span>
The alpha-Gal4 mouse monoclonal (sc-510), alpha-CDK8 goat polyclonal (sc-1521), alpha-CDK9 goat polyclonal (sc-7331), alpha-CycT1 goat polyclonal (sc-8127), alpha-Med6 goat polyclonal (sc-9434), alpha-GCN5 goat polyclonal (sc-6303); alpha-TRRAP rabbit polyclonal (sc-11411), alpha-TAF1 mouse monoclonal (sc-735), alpha-TAF5 mouse monoclonal (sc-743), alpha-Sp1 rabbit polyclonal (sc-59X), and alpha-alpha tubulin mouse monoclonal (sc-5268) antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, California, United States). The alpha-RNA polymerase II mouse monoclonal antibody (8WG16) was obtained from BAbCO (Berkeley, California, United States). The alpha-Tat rabbit antiserum was obtained from the National Institutes of Health AIDS Research and Reference Reagent Program (catalog number 705; [57]). The alpha-TBP mouse monoclonal antibody (SL30-3-563) was provided by Nouria Hernandez; the alpha-TAF2, alpha-TAF4, alpha-TAF6, alpha-TAF7, alpha-TAF8, alpha-TAF9, alpha-TAF11, alpha-TAF12, alpha-TAF13, and alpha-hSpt3 rabbit polyclonal antibodies were provided by Robert Roeder; the alpha-Mot1 rabbit polyclonal antibody was provided by Franklin Pugh; and the alpha-PAF65beta rabbit polyclonal antibody was provided by Yoshihiro Nakatani.
###end p 53
###begin title 54
Transcription
###end title 54
###begin p 55
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b58">58</xref>
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
Transcription was measured either by RT-PCR analysis from total RNA isolated from transfected cells or by chloramphenicol acetyl transferase (CAT) assay [58] using 14C chloramphenicol followed by thin layer chromatography. Signals were visualized by autoradiography and quantitated using National Institutes of Health Image 1.62 software.
###end p 55
###begin title 56
ChIP assay
###end title 56
###begin p 57
###xml 119 120 117 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 143 145 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b59">59</xref>
###xml 1945 1947 1923 1925 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sub>
###xml 1948 1950 1926 1928 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">39</sub>
###xml 1953 1954 1931 1932 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 2137 2138 2115 2116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
HeLa and 293T cells were transfected with 10 mug of effector plasmids and 5 mug of reporter plasmid using standard CaCl2 transfection methods [59]. Forty-eight hours after transfection, cells were cross-linked by adding formaldehyde to the medium (1% final concentration) and incubated for 10 min at room temperature. The cross-linking reaction was quenched by adding glycine to a final concentration of 0.125 M and incubating for an additional 10 min at room temperature. Cells were then washed with ice-cold PBS containing protease inhibitors, scraped in the same buffer, and washed in PBS. Cells were then lysed in SDS-lysis buffer (1% SDS, 50 mM Tris-HCl [pH 8.0], 10 mM EDTA, and protease inhibitors), and sonicated at least 6-8 times at output 8 for 10 s, with 2 min incubation on ice in between. Lysates were centrifuged at 15,000 rpm for 15 min at 4 degreesC; 5% of the lysates were kept as input. Lysates were diluted 10-fold with ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl [pH 8.0], 16.7 mM NaCl, and protease inhibitors) and pre-cleared with 80 mul of Protein A Agarose-50% Slurry (Upstate Biotechnology, Lake Placid, New York, United States) for 30 min at 4 degreesC with constant agitation. The agarose beads were pelleted, and the supernatant was incubated overnight with the primary antibody. To each tube, 50 mul of Salmon Sperm DNA/Protein A Agarose-50% Slurry (Upstate Biotechnology) was added, and the mixture was incubated for 1 h at 4 degreesC. The agarose beads were pelleted by gentle centrifugation, the supernatant was removed, and the pellet was washed twice with low-salt immune complex wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl [pH 8.0], and 150 mM NaCl), once with high-salt immune complex wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl [pH 8.0], and 500 mM NaCl), once with LiCl immune complex wash buffer (0.25 M LiCl, 1% NP40, 1% C24H39NaO4, 1 mM EDTA, and 10 mM Tris-HCl [pH 8.0]), and twice with TE (10 mM Tris-HCl [pH 8.0] and 1 mM EDTA). Chromatin was eluted with freshly prepared elution buffer (1% SDS and 0.1 M CHNaO3). After reversal of the cross-links, the samples were treated with proteinase K for 1 h at 45 degreesC, extracted by phenol/chloroform, and ethanol precipitated. The pellet was resuspended in TE, and PCR was performed. Autoradiograms were scanned and quantitated by the National Institutes of Health ImageJ program. IP DNA was quantitated and presented as the ratio of IP to input. Primer sequences are available upon request.
###end p 57
###begin title 58
TAF inactivation
###end title 58
###begin p 59
###xml 35 37 35 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0030044-b60">60</xref>
For TAF1 inactivation, ts13 cells [60] were initially cultured at the permissive temperature (33 degreesC), after which one set of 6-well plates was shifted to the non-permissive temperature (39.5 degreesC) while another set was kept at 33 degreesC. Sixteen hours later, cells were co-transfected with a plasmid expressing a transcriptional activator (Gal4-VP16, E1a, or Tat) and a luciferase reporter plasmid, and incubated further for 24 h prior to measuring transcription by luciferase assay. For shRNA-mediated inactivation of TAFs, 293A cells were transfected with either pcDNA3 (Invitrogen, Carlsbad, California, United States) or a TAF5 or TAF12 shRNA expression vector (Open Biosystems, Huntsville, Alabama, United States), and 18 h later were co-transfected with effector and reporter plasmids. Transcription activation was monitored by luciferase activity 24 h following transfection.
###end p 59
###begin title 60
Supporting Information
###end title 60
###begin title 61
Accession Numbers
###end title 61
###begin p 62
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DM</italic>
###xml 191 197 191 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR</italic>
The LocusLink () accession numbers for the genes and gene products discussed in this paper are CDK8 (1024), CDK9 (1025), CIITA (4261), CycT1 (904), GAPDH (2597), hGCN5 (2648), HLA-DM (3109), HLA-DR (3122), hSpt3 (8464), MED6 (10001), Mot1 (9044), PAF65beta (27097), RBP1 (5430), TAF1 (6872), TAF11 (6882), TAF12 (6883), TAF13 (6884), TAF2 (6873), TAF4 (6874), TAF5 (6877), TAF6 (6878), TAF7 (6979), TAF8 (129685), TAF9 (6880), Tat (155871), TBP (6908), TFIIB (2959), and TRRAP (8295).
###end p 62
###begin p 63
We thank Robert Roeder, Nouria Hernandez, Yoshihiro Nakatani, and Franklin Pugh for providing antibodies; Claude Gazin, Bryan Cullen, and Walter Schaffner for providing plasmids; Maria Zapp and Ellen Kittler for providing 8E5/LAV and U1 cells and advice; and Sara Evans for editorial assistance. This work was supported in part by an National Institutes of Health grant to MRG. MRG is an investigator of the Howard Hughes Medical Institute.
###end p 63
###begin p 64
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
The general transcription factors of RNA polymerase II
###end article-title 66
###begin article-title 67
Biochemistry and structural biology of transcription factor IID (TFIID)
###end article-title 67
###begin article-title 68
TAFs revisited: More data reveal new twists and confirm old ideas
###end article-title 68
###begin article-title 69
TBP-associated factors (TAFIIs): Multiple, selective transcriptional mediators in common complexes
###end article-title 69
###begin article-title 70
How eukaryotic transcriptional activators work
###end article-title 70
###begin article-title 71
Activators and targets
###end article-title 71
###begin article-title 72
The role of general initiation factors in transcription by RNA polymerase II
###end article-title 72
###begin article-title 73
Transcriptional activation by recruitment
###end article-title 73
###begin article-title 74
Transcription of eukaryotic protein-coding genes
###end article-title 74
###begin article-title 75
Orchestrated response: A symphony of transcription factors for gene control
###end article-title 75
###begin article-title 76
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Tat: Coping with negative elongation factors
###end article-title 76
###begin article-title 77
Tackling Tat
###end article-title 77
###begin article-title 78
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV Tat, its TARgets and the control of viral gene expression
###end article-title 78
###begin article-title 79
P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II
###end article-title 79
###begin article-title 80
Cyclin T: Three forms for different roles in physiological and pathological functions
###end article-title 80
###begin article-title 81
TAF-Containing and TAF-independent forms of transcriptionally active TBP in vivo
###end article-title 81
###begin article-title 82
###xml 20 25 <span type="species:ncbi:4932">yeast</span>
Distinct classes of yeast promoters revealed by differential TAF recruitment
###end article-title 82
###begin article-title 83
Binding of TBP to promoters in vivo is stimulated by activators and requires Pol II holoenzyme
###end article-title 83
###begin article-title 84
Enhancement of TBP binding by activators and general transcription factors
###end article-title 84
###begin article-title 85
Transcriptional enhancers-On/off gene regulation as an adaptation to silencing in higher eukaryotic nuclei
###end article-title 85
###begin article-title 86
###xml 55 59 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences
###end article-title 86
###begin article-title 87
Mechanisms of viral activators
###end article-title 87
###begin article-title 88
A cellular transcription factor E4F1 interacts with an E1a-inducible enhancer and mediates constitutive enhancer function in vitro
###end article-title 88
###begin article-title 89
###xml 117 122 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA
###end article-title 89
###begin article-title 90
In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment
###end article-title 90
###begin article-title 91
Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus
###end article-title 91
###begin article-title 92
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
###end article-title 92
###begin article-title 93
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency
###end article-title 93
###begin article-title 94
The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1
###end article-title 94
###begin article-title 95
###xml 26 31 <span type="species:ncbi:9606">human</span>
Cloning and expression of human TAFII250: A TBP-associated factor implicated in cell-cycle regulation
###end article-title 95
###begin article-title 96
###xml 52 87 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein
###end article-title 96
###begin article-title 97
Delineating minimal protein domains and promoter elements for transcriptional activation by lentivirus Tat proteins
###end article-title 97
###begin article-title 98
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element
###end article-title 98
###begin article-title 99
Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo
###end article-title 99
###begin article-title 100
Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes
###end article-title 100
###begin article-title 101
###xml 38 41 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription
###end article-title 101
###begin article-title 102
The class II transactivator CIITA is a transcriptional integrator
###end article-title 102
###begin article-title 103
###xml 101 104 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection
###end article-title 103
###begin article-title 104
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication
###end article-title 104
###begin article-title 105
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV TAR: An RNA enhancer?
###end article-title 105
###begin article-title 106
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
###end article-title 106
###begin article-title 107
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation
###end article-title 107
###begin article-title 108
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation
###end article-title 108
###begin article-title 109
###xml 23 51 <span type="species:ncbi:12721">human immunodeficiency virus</span>
The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation
###end article-title 109
###begin article-title 110
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Transcriptional pausing at +62 of the HIV-1 nascent RNA modulates formation of the TAR RNA structure
###end article-title 110
###begin article-title 111
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters
###end article-title 111
###begin article-title 112
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 inducer of short transcripts activates the synthesis of 5,6-dichloro-1-beta-D-benzimidazole-resistant short transcripts in vitro
###end article-title 112
###begin article-title 113
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Tat protein trans-activates transcription in vitro
###end article-title 113
###begin article-title 114
Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain
###end article-title 114
###begin article-title 115
Analysis of the role of the transcription factor ATF in the assembly of a functional preinitiation complex
###end article-title 115
###begin article-title 116
###xml 33 37 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Transcriptional 'enhancers' from SV40 and polyoma virus show a cell type preference
###end article-title 116
###begin article-title 117
Transcription activation by the adenovirus E1a protein
###end article-title 117
###begin article-title 118
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
ZFX transactivation of the HIV-1 LTR is cell specific and depends on core enhancer and TATA box sequences
###end article-title 118
###begin article-title 119
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: Implications for Tat function
###end article-title 119
###begin article-title 120
GAL4-VP16 is an unusually potent transcriptional activator
###end article-title 120
###begin article-title 121
###xml 20 48 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism
###end article-title 121
###begin article-title 122
###xml 20 48 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events
###end article-title 122
###begin article-title 123
Use of eukaryotic expression technology in the functional analysis of cloned genes
###end article-title 123
###begin article-title 124
High-efficiency transformation of mammalian cells by plasmid DNA
###end article-title 124
###begin article-title 125
Temperature sensitive mutants of BHK cells affected in cell cycle progression
###end article-title 125
###begin title 126
Abbreviations
###end title 126
###begin p 127
adenovirus
###end p 127
###begin p 128
chromatin immunoprecipitation
###end p 128
###begin p 129
cyclin T1
###end p 129
###begin p 130
general transcription factor
###end p 130
###begin p 131
###xml 0 28 <span type="species:ncbi:12721">human immunodeficiency virus</span>
human immunodeficiency virus type I
###end p 131
###begin p 132
long terminal repeat
###end p 132
###begin p 133
major histocompatibility complex
###end p 133
###begin p 134
open reading frame
###end p 134
###begin p 135
pre-initiation complex
###end p 135
###begin p 136
positive transcription elongation factor b
###end p 136
###begin p 137
short hairpin RNA
###end p 137
###begin p 138
 TATA-box-binding protein associated factor
###end p 138
###begin p 139
 TATA-box-binding protein
###end p 139
###begin p 140
transcription complex
###end p 140
###begin title 141
Figures and Tables
###end title 141
###begin title 142
Diverse Activators Function by Increasing TC Assembly
###end title 142
###begin p 143
(A) Gal4-VP16. Left: a CAT reporter construct containing the E1b core promoter and four Gal4-binding sites (G4E1bCAT) was transiently trans-fected into 293T cells, together with a plasmid expressing Gal4-VP16. Middle: transcription levels were determined by quantitating CAT reporter activity. Right: TC assembly was analyzed by a ChIP assay using the indicated antibodies. The percentage of DNA immunoprecipitated relative to input is indicated. The location of the primers used in the ChIP assay to analyze the promoter (black) or ORF (gray) is schematically shown on the left.
###end p 143
###begin p 144
###xml 103 107 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 4 8 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 96 102 <span type="species:ncbi:9986">rabbit</span>
###xml 153 157 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
(B) SV40 enhancer. Shown on the left is a schematic diagram of a construct containing a minimal rabbit beta-globin promoter and harboring or lacking the SV40 enhancer. Also shown is transcription analysis by CAT assay (middle) and TC assembly (right) in transiently transfected HeLa cells.
###end p 144
###begin p 145
(C) Ad E1a. Left: a CAT reporter construct containing the Ad E4 promoter and upstream ATF-binding sites (E4CAT) was transiently transfected into HeLa cells, together with a plasmid expressing Ad E1a. Middle: transcription analysis by CAT assay is shown. Right: TC assembly is shown.
###end p 145
###begin title 146
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 Tat Protein Stimulates TC Assembly through Recruitment of TBP in the Absence of TAFs
###end title 146
###begin p 147
###xml 84 87 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) A CAT reporter construct containing the TAR element and Sp1-binding sites ([-83]HIV LTRCAT) was transiently transfected into 293T cells, together with a plasmid expressing Tat. Left: transcription analysis by CAT assay is shown. Middle and right: TC assembly is shown. Bottom: a schematic diagram of the CAT reporter construct is shown.
###end p 147
###begin p 148
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(B) TC assembly was monitored in a chronically HIV-1-infected cell line, 8E5/LAV, that harbors an integrated provirus that is constitutively transcribed. Virus production was confirmed by analysis of p24 levels and reverse transcriptase activity in the culture medium (data not shown).
###end p 148
###begin p 149
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(C) TC assembly was monitored in the chronically infected cell line U1 on the integrated HIV-1 LTR in the presence or absence of PMA.
###end p 149
###begin title 150
###xml 30 33 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
TAFs Are Not Recruited to the HIV 1-LTR and Not Required by Tat for Transcription Activation
###end title 150
###begin p 151
###xml 95 100 <span type="species:ncbi:9606">human</span>
(A) TC assembly was analyzed by a ChIP assay using antibodies directed against nine additional human TAFs, four subunits of the S TAGA complex, and Mot1. TAFs that are also present in S TAGA are indicated by asterisks. Bottom: schematic diagrams of the promoter constructs are shown.
###end p 151
###begin p 152
(B) Transcription analysis in ts13 cells, which harbor a temperature-sensitive mutation in TAF1. Ts13 cells grown at the permissive or non-permissive temperature were transiently transfected with a luciferase reporter plasmid and a plasmid expressing a transcriptional activator. Transcription was monitored by luciferase activity, and normalized relative to activity at the permissive temperature.
###end p 152
###begin p 153
(C) Left: immunoblot analysis is shown. 293A cells were transfected with a TAF5 or TAF12 shRNA expression vector or an empty vector (control) and analyzed by immunoblotting using the indicated antibodies. Right: transcription levels were monitored by luciferase reporter activity in shRNA-treated cells, and normalized relative to luciferase activity in non-shRNA-treated cells.
###end p 153
###begin title 154
Tat and P-TEFb Direct Recruitment of TBP in the Absence of TAFs When Tethered to DNA
###end title 154
###begin p 155
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 165 168 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Transcription (left) and TC assembly (right) were examined using an HIV-1 LTR derivative that lacks the TAR element and contains upstream Gal4-binding sites (G6[-83]HIV LTRDeltaTARCAT; bottom) and a series of Gal4 fusion proteins, as indicated.
###end p 155
###begin title 156
Tat and P-TEFb Direct Recruitment of TBP in the Absence of TAFs When Tethered to RNA
###end title 156
###begin p 157
###xml 110 115 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 223 226 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Transcription (left) and TC assembly (right) were examined using a Rev-Tat or Rev-CycT1 fusion protein and an HIV-1 LTR derivative in which the TAR element was replaced by stem loop IIB (SLIIB), a Rev-protein-binding site (HIV SLIIBCAT; bottom).
###end p 157
###begin title 158
The Cellular Activator CIITA Directs Recruitment of TBP in the Absence of TAFs
###end title 158
###begin p 159
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DM</italic>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR,</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
TC assembly was monitored on the promoters of HLA-DM and HLA-DR, two MHC class II genes known to use CIITA, and, as a negative control, GAPDH.
###end p 159
###begin p 160
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. TR and MRG conceived and designed the experiments. TR and SWGC performed the experiments. TR, SWGC, and MRG analyzed the data. TR and SWGC contributed reagents/materials/analysis tools. TR and MRG wrote the paper.
###end p 160
###begin p 161
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Citation: Raha T, Cheng SWG, Green MR (2005) HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol 3(2): e44.
###end p 161

